Macquarie University spinout Celosia Therapeutics has scored a $2 million grant, the largest, from $7m shared between six startups in the first round of the NSW Emerging Technology Commercialisation Fund.
More than 250 businesses applied to the state government program. Celosia, which is developing a second gene therapy for motor neurone disease (MND), was the only applicant to receive the maximum grant. The other recipients were Agscent, Hullbot, Syenta, Deteqt and Zetifi.
Celosia CEO Dr Kathryn Sunn said grant funding “will help us expand our MND pipeline, supporting candidate development, manufacturing work and preclinical studies alongside our lead program, CTx1000, which is currently being studied in patients with sporadic amyotrophic lateral sclerosis (ALS), the most common form of MND”.
Celosia will work with the NSW Viral Vector Manufacturing Facility over two years to develop a process that can reliably produce the new therapy in larger quantities and test its quality ahead of future clinical studies.
The biotech grew out of research by Macquarie University professors Lars Ittner and Yazi Ke into a protein called TDP-43. In around 97% of ALS cases, the protein forms toxic clumps inside nerve cells. CTx1000 is designed to help cells clear those clumps while preserving the healthy protein they need to function.
Celosia previously raised $16.75 million in a 2024 Series A led by Uniseed, with backing from hedge fund manager Iomar Barrett, who was living with ALS.
Get the best of Startup Daily straight to your inbox
Want to know the latest in startup news? Subscribe to our daily news and analysis coverage on what’s happening to ANZ startups, investors and the broader ecosystem. And best of all, it’s FREE!
By continuing, you agree to our Terms & Conditions and Privacy Policy .
In March Celosia said its first participant in a phase 1b trial assessing the safety and tolerability of a single dose of CTx1000 had received it.
From cattle to hulls
The other five grants recipients span diagnosing sick cattle to lowering shipping fuel bills.
Agscent , which received $1.25m will take its cattle breath test into commercial feedlots. It aims to detect bovine respiratory disease in under a minute, so farmers can treat livestock before visible symptoms appear. The startup previously raised $5m in July at a $26.9m valuation.
Hullbot is developing a ship-mounted docking station that can launch and retrieve its hull-cleaning robot at sea. Deteqt, a University of Sydney spinout backed by Main Sequence, is preparing to manufacture a magnetic sensor measuring about one square millimetre for applications including mineral exploration.
Syenta , a spinout from ANU, is developing finer connections between chips to improve performance and cut energy use, having raised $36 in a Series A earlier this year.
Deteqt , a Sydney Uni spinout, also backed by Main Sequence , is building a quantum magnetometer that’s about 1mm sq in size. The low powers sensors can be used for mineral exploration to detect magnetic signals from ore bodies and underwater objects.
Hullbot , which banked a $6m Series A last year , is building a docking station that stays on a ship and launches and retrieves its hull-cleaning robot at sea to remove marine growth before it creates drag that pushes up fuel bills.
Zetifi is developing ZetiSky, a vehicle antenna for people working alone beyond mobile coverag e. It switches between mobile towers and satellites and gives emergency messages priority.
The $20 million emerging technology commercialisation fund runs for three years as part of the NSW Innovation Blueprint 2035. The next round opens in 2027.
Simon has been editor of Startup Daily since 2019. He hosted the Startup Daily show on streaming service ausbiz.com.au from 2020 to 2023, and now, the weekly podcast Startup 360. He was previously associate editor of Business Insider Australia, a national restaurant critic, editor of The Good Food Guide, and newspaper proprietor during a 30-plus-years career in journalism and publishing. He’s also an investor in early stage startups.
Recommended for you
Macquarie Uni biotech spin out raises $16.8m Series A
Startup Daily Nov 29, 2024
Uniseed adds another $25m from UniSuper to commercialise academic research
Startup Daily May 20, 2025
The NSW government is getting into startup lending with a $20 million commercialisation fund
Simon Thomsen Mar 10, 2026



